Abstract:ID 99880 Poster Board 540 Aim: Cocaine use disorder (CUD) is characterized by cocaine-induced alterations in dopamine release in the nucleus accumbens (NAc). Critically, sex differences in dopamine release both in basal and drug-induced processes play a causal role in sex-specific behaviors associated with CUD – where females show enhanced vulnerability. While work has focused on sex differences in the anatomy of dopamine neurons and relative dopamine levels, an important characteristic of dopamine release from axon terminals is that it is rapidly modulated by local regulatory mechanisms independent of somatic activity. GABA released from local microcircuitry in the NAc has been shown to play a critical role in regulating dopamine release at the terminals through ionotropic GABA-A and G i -coupled GABA-B receptors and has also been implicated in cocaine-induced processes. Here we define basal sex differences in dopamine release regulation via GABA in the NAc and show how this is dysregulated by chronic cocaine exposure. Methods: To dissociate dopamine terminal regulation from somatic regulation, we utilize ex vivo fast scan cyclic voltammetry and optogenetics in striatal brain slices. Dopamine release was evoked from terminals via electrical or optogenetic stimulation, and GABA receptor modulation of this signal was determined via bath application of picrotoxin (GABA-A antagonist), muscimol (GABA-A agonist), saclofen (GABA-B antagonist), and baclofen (GABA-B agonist) to slices. This was done in the absence and presence of nicotinic acetylcholine receptor antagonist DHßE to determine if GABA receptor modulation was through cholinergic interneurons. Results: GABA-A and GABA-B receptor agonists decreased dopamine release in the striatum similarly in males and females. However, sex differences were observed in antagonizing GABA receptors following both electrical and optogenetic stimulation. Picrotoxin, GABA-A antagonist, increased dopamine release to a greater extent in females compared to males, and this effect remained in the presence of DHßE. GABA-B antagonist saclofen increased dopamine release to a greater extent in males compared to females, however, this sex difference was only in the absence of DHßE. Lastly, GABA mediated inhibition of dopamine release was blunted following cocaine exposure in both males and females. Conclusion: These data highlight differential effects in GABA receptor regulation of dopamine release between sexes. First, there is enhanced GABA-B-mediated inhibition in males that is modulated through cholinergic interneurons. Secondly, GABA-A mediated inhibition was enhanced in females, and this effect was independent of nicotinic receptor activation, suggesting this mechanism is directly at the dopamine terminals. Finally, these mechanisms undergo cocaine-induced plasticity in both males and females. The results of these studies will contribute to the understanding of how sex fits into the comprehensive framework for dopamine release regulation and how dysregulation of these processes influences the trajectory of CUD in both sexes.

Differential Effects in GABA Receptor Regulation Between Sexes and its Role in Cocaine Use Disorder

Shared and Divergent Transcriptomic Regulation in Nucleus Accumbens D1 and D2 Medium Spiny Neurons by Cocaine and Morphine

Cocaine-Induced Chromatin Modifications Associate with Increased Expression and Three-Dimensional Looping of Auts2.

A novel role for E2F3b in regulating cocaine action in the prefrontal cortex

Sex-Dependent Differences in the Neural Correlates of Cocaine and Emotional Cue-Reactivity in Regular Cocaine Users and Non-Drug-Using Controls: Understanding the Role of Duration and Severity of Use

Sex differences in hippocampal β-adrenergic receptor subtypes drive retrieval, retention, and learning of cocaine-associated memories

Sex-Specific ADNP/NAP (Davunetide) Regulation of Cocaine-Induced Plasticity

Circuit-wide Gene Network Analysis Reveals Sex-Specific Roles for Phosphodiesterase 1b in Cocaine Addiction

Brain structural differences in cocaine use disorder: Insights from multivariate and neurotransmitter analyses

Molecular Mechanisms Underlying Sex and Treatment-Dependent Differences in an Animal Model of Cue-Exposure Therapy for Cocaine Relapse Prevention

Enhanced peripheral levels of BDNF and proBDNF: elucidating neurotrophin dynamics in cocaine use disorder

Effects of access condition on substance use disorder-like phenotypes in male and female rats self-administering MDPV or cocaine

Cocaine‐induced Synaptic Structural Modification is Differentially Regulated by Dopamine D1 and D3 Receptors‐mediated Signaling Pathways

Developmental Disruption of Gamma-Aminobutyric Acid Function in the Medial Prefrontal Cortex by Noncontingent Cocaine Exposure During Early Adolescence

A multi-omics and cell type-specific characterization of the ventral striatum in human cocaine use disorder

Multi-omics profiling of DNA methylation and gene expression alterations in human cocaine use disorder

Interactions between estradiol and ERK, but not mTOR, signaling is necessary for enhanced cocaine-induced conditioned place preference in female rats

Sex and hormonal effects on drug cue-reactivity and its regulation in human addiction

Sex-specific effects of chronic stress prior to cocaine exposure on cue- vs drug-induced relapse after prolonged abstinence

Estradiol reduction through aromatase inhibition impairs cocaine seeking in male rats